Allo-HLA reactivity of virus-specific memory T cells is common by Avital L. Amir, Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate.

Slides:



Advertisements
Similar presentations
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.
Advertisements

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Blockade of osteopontin reduces alloreactive CD8 + T cell– mediated graft-versus-host disease by Fang Zhao, Yi Zhang, Hao Wang, Min Jin, Shan He, Yufang.
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass by Grace M. Lee, Ian J. Welsby,
Increased peripheral platelet destruction and caspase-3– independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients by.
Sharing cross-reactive groups of MHC class I improves long-term graft survival Yvo W.J. Sijpkens, M.D., Ilias I.N. Doxiadis, Johan W. de Fijter, Marko.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.
DAR, a New RhD Variant Involving Exons 4, 5, and 7, Often in Linkage With ceAR, a New Rhce Variant Frequently Found in African Blacks by M.B. Hemker, P.C.
Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study by Henk M. Lokhorst, Bronno van der.
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
by Bernhard Nieswandt, and Johan W. M. Heemskerk
Do HSCs divide asymmetrically?
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima
TCR-MHC-peptide(s): in vivo veritas
“Vitamin hypothesis”: explanation for allergy increase?
Defects in DBA: more than meets the eye
Next-generation leukemia immunotherapy
by Venetia Bigley, Laura E. Spence, and Matthew Collin
by Pieternella S. in `t Anker, Sicco A
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma by Lotta.
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
Tax fingerprint in adult T-cell leukemia
The Fanconi anemia cell line HSC536N is not sensitive to interferon-γ and does not cleave PARP in response to Fas-mediated cell killing by Tim R. Rutherford,
How I treat elderly patients with myeloma
Nonmyeloablative conditioning for relapsed follicular lymphoma
HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1- Specific CD4+ T Cell Responses Showing Immunogenicity of all HLA-DPB1.
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
CMV: when bad viruses turn good
An Unusual Cause of Abdominal Pain in Sickle Cell Disease
by Corey S. Cutler, John Koreth, and Jerome Ritz
Engineering regulatory T cells against factor VIII inhibitors
Promiscuity of the AlloHLA-A2 Restricted T Cell Repertoire Hampers the Generation of Minor Histocompatibility Antigen-specific Cytotoxic T Cells across.
In situ identification of allospecific B cells using pentamers
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
Suppression, surprise: galectin-10 and Treg cells
Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State by Stephanie.
Has the T cell bitten off more than it can chew?
T cell receptor Vβ (TCR-Vβ) expression in a drug-specific T cell line (TCL) and specificity assay of a TCL of patient P1. T cell receptor Vβ (TCR-Vβ) expression.
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent?
by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor.
by Ineke J. M. ten Berge, and René A. W. van Lier
Lymphoma spread? Target CD47-SIRPα!
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR)
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,
Anergy: the CLL cell limbo
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E
Volume 26, Issue 5, Pages (May 2018)
by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F
Changes throughout time in the lineage content of clones regenerated in secondary mice. Changes throughout time in the lineage content of clones regenerated.
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Bridge to transplant following Bv+Bs regimen.
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses 
Minor Histocompatibility Antigen DDX3Y Induces HLA-DQ5-Restricted T Cell Responses with Limited TCR-Vβ Usage Both In Vivo and In Vitro  David Laurin,
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Rituximab immunotherapy: it’s getting personal
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
A binding relationship with thrombin
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Cold agglutinin disease
New concepts for anticoagulant therapy in persons with hemophilia
Presentation transcript:

Allo-HLA reactivity of virus-specific memory T cells is common by Avital L. Amir, Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate S. Hagedoorn, Renate de Boer, Menno A. W. G. van der Hoorn, Michel G. D. Kester, Ilias I. N. Doxiadis, J. H. Frederik Falkenburg, Frans H. J. Claas, and Mirjam H. M. Heemskerk Blood Volume 115(15): April 15, 2010 ©2010 by American Society of Hematology

Alloreactivity of virus-specific T-cell lines. Avital L. Amir et al. Blood 2010;115: ©2010 by American Society of Hematology

Allo-HLA reactivity of virus-specific T-cell clones. Avital L. Amir et al. Blood 2010;115: ©2010 by American Society of Hematology

Variable allo-HLA recognition by T-cell clones with the same specificity but different TCR Vβ usage. Avital L. Amir et al. Blood 2010;115: ©2010 by American Society of Hematology

The potency of the alloreactivity exerted by virus-specific T cells. Avital L. Amir et al. Blood 2010;115: ©2010 by American Society of Hematology

One TCR complex mediates both virus specificity and allo-HLA reactivity. Avital L. Amir et al. Blood 2010;115: ©2010 by American Society of Hematology

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.